Artificial intelligence (AI) is reshaping healthcare, and its use is becoming a reality in many medical fields and specialties. AI, machine learning (ML), natural language processing (NLP) and deep learning (DL) enable healthcare stakeholders and medical professionals to identify healthcare needs and solutions faster with more accuracy, using data patterns to make informed medical or business...
Drug-discovery startup Insilico Medicine has scored a whopping $225 million in a Series C funding round led by Warburg Pincus.
This comes roughly two years after the New York and Hong Kong-based startup raised $37 million in Series B funding. The company now boasts of more than $310 million in funding.
Qiming Venture Partners, Pavilion Capital, Eight Roads Ventures, Lilly Asia Ventures,...
Ping An Insurance (Group) Company of China has reported that its researchers have come up with a deep learning framework for drug discovery.
A research team from Ping An Healthcare Technology Research Institute and Beijing's Tsinghua University developed the said framework; its findings were published in the peer-reviewed journal Briefings in Bioinformatics.
WHY IT MATTERS
The researchers created...
Silicon Valley giant NVIDIA is teaming up with pharma company AstraZeneca and the University of Florida on new artificial intelligence research projects aimed at boosting drug discovery and patient care.
This morning NVIDIA and AstraZeneca revealed a new drug-discovery model called MegaMoIBART, which is aimed at "reaction prediction, molecular optimization and de novo molecular generation."...
insitro, an artificial intelligence drug discovery startup, has added a $400 million Series C round to its already impressive fundraising haul. The financing is set to close during the first full week of April, according to the company.
Canadian Pension Plan Investment Board led the raise, which also included a laundry list of participants. These names include: Andreessen Horowitz, funds and...
This morning Israeli "Digital X-ray" company Nanox announced a new deal with medical data and image management firm Ambra Health. The agreement will see Ambra's cloud software integrated with the digital component of Nanox's in-development imaging systems, and according to the companies will streamline image management while making it easier to access for providers and patients.
"It is our intent...
insitro and Exscientia, two platforms using artificial intelligence to drive the discovery of new drugs, announced this morning the raise of $143 million and $60 million, respectively, from investors.
insitro's oversubscribed Series B round was headed by Andreessen Horowitz, and joined by new backers Canada Pension Plan Investment Board, T. Rowe Price Associates, BlackRock, Casdin Capital, HOF...
_16.jpg?itok=d2vUI8K5)
